Latest News about DELCF
Recent news which mentions DELCF
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
From Benzinga
Rolling The Perfect Joint For A Quick & Efficient High, Researchers Say It Doesn't Involve Strong Weed
July 04, 2023
Tickers
DELCF
From Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
From Benzinga
From Benzinga
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
September 22, 2022
From Benzinga
Strategic Cannabis Execs Making Changes At Companies You Know: Curaleaf, Valens, Copperstate & Delic
July 22, 2022
From Benzinga
Delic Holdings Shares Corporate Updates: Revenues Grow As Ketamine Clinic Chain Continues Expansion
July 22, 2022
From Benzinga
Nation's Largest Ketamine Therapy Provider Offers Patient Resource For Holistic Mental Health Treatments
June 30, 2022
Tickers
DELCF
From Benzinga
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
May 19, 2022
From Benzinga
From Benzinga
Delic Holdings Provides Default Status Update
May 16, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Delic Labs Receives Exemption To Conduct Research On MDMA, LSD And Other Psychedelic Compounds
April 13, 2022
Tickers
DELCF
From Benzinga
Ketamine Wellness Centers Offering FDA Approved Esketamine Treatment For Major Depressive Disorder
March 30, 2022
Tickers
DELCF
From Benzinga
Cannabis Dispensary Roundup: Delic Holdings, Ayr Wellness, High Tide
January 18, 2022
From Benzinga
Delic Introduces Industry's First Family Support & Education Program At Ketamine Wellness Centers
November 18, 2021
Tickers
DELCF
From Benzinga
Delic Closes $10M Merger With Chain Of Ketamine Clinics
November 09, 2021
Tickers
DELCF
From Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
From Benzinga
Delic Labs Applies For Dealer's License To Work With MDMA And LSD For Medical Purposes
October 06, 2021
Tickers
DELCF
From Benzinga
Delic Teams Up With Paradigm To Create Ketamine Toxicology Testing Solution, Raises $7M For Expansion
September 30, 2021
Tickers
DELCF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.